Skarvan Amends Electromed Stake Filing

TL;DR

Skarvan updated her Electromed stake filing, date of event Nov 19.

AI Summary

Kathleen S. Skarvan filed an amendment (No. 3) to her Schedule 13D on November 21, 2024, regarding her beneficial ownership of Electromed, Inc. common stock. The filing indicates a change in the date of the event requiring this filing to November 19, 2024. Skarvan's address is listed as 500 Sixth Avenue NW, New Prague, MN 56071.

Why It Matters

This filing updates information regarding significant beneficial ownership of Electromed, Inc., which can influence investor perception and stock trading activity.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing and does not appear to involve new aggressive actions or significant changes in ownership percentage.

Key Players & Entities

• Electromed, Inc. (company) — Subject company
• Kathleen S. Skarvan (person) — Filing person
• November 19, 2024 (date) — Date of event requiring filing
• November 21, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti
• $0.001 — relates to the Common Stock, par value $0.001 per share (“Common Stock”),
• $28.1641 — held directly with an average price of $28.1641. On November 19, 2024 the Reporting Per
• $27.9221 — ck held indirectly at average prices of $27.9221 and $27.9706, respectively. These sales
• $27 — ectly at average prices of $27.9221 and $27.9706, respectively. These sales of shar

Filing Documents

• skarvan241208_13da.htm (SC 13D/A) — 44KB
• 0000897101-24-000592.txt ( ) — 45KB

From the Filing

SC 13D/A 1 skarvan241208_13da.htm SC 13D/A UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 3) Under the Securities Exchange Act of 1934 ELECTROMED, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 285409108 (CUSIP Number) Kathleen S. Skarvan 500 Sixth Avenue NW New Prague, MN 56071 952-758-9299 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 19, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 285409108 1. Names of reporting persons Kathleen S. Skarvan 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Source of Funds (See Instructions) SC/PF 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization USA Number of Shares Beneficially Owned by Each Reporting Person With: 7. Sole Voting Power 303,094 8. Shared Voting Power 28,989 9. Sole Dispositive Power 303,094 10. Shared Dispositive Power 28,989 11. Aggregate Amount Beneficially Owned by Each reporting person 332,083 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 3.93% (1) 14. Type of reporting person (See Instructions) IN (1) The percentage is based upon 8,458,005 shares of common stock outstanding as of November 7, 2024 as reported by the Issuer in its latest Quarterly Report on Form 10-Q, as filed with the Securities and Exchange Commission on November 12, 2024. EXPLANATORY NOTE This Amendment No. 3 to Schedule 13D (“Amendment No. 3”) is being filed solely to consistently state Kathleen S. Skarvan’s (the “Reporting Person”) positions with Electromed, Inc. (the “Issuer”). This Amendment No. 3 amends and supplements the initial statement on Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) by the Reporting Person on July 1, 2022, as amended by Amendment No. 1 to Schedule 13D filed with the SEC on July 12, 2022, and Amendment No. 2 to Schedule 13D filed with the SEC on February 14, 2023 (as amended, this “Schedule 13D”). Item 1. Security and Issuer This Schedule 13D relates to the Common Stock, par value $0.001 per share (“Common Stock”), of the Issuer, 500 Sixth Avenue NW, New Prague, MN 56071. Item 2. Identity and Background (a) The person filing this Schedule 13D is Kathleen S. Skarvan (b) (c) Principal occupation: Retired (d) Criminal proceedings: The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) The Reporting Person has not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which the Reporting Person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) The Reporting person is a citizen of the United States of America. Item 3. Source and Amount of Funds or Other Consideration Not applicable. Item 4. Purpose of Transaction Item 4 is hereby amended and supplemented as follows: On November 18, 2024, the Reporting Person sold 42,453 shares of Common Stock held directly with an average price of $28.1641. On November 19, 2024 the Reporting Person sold 50,602 shares of Common Stock held directly and 56,945 shares of Common Stock held indirectly at average prices of $27.9221 and $27.9706, respecti

View Full Filing

View this SC 13D/A filing on SEC EDGAR